Ampersand Capital Partners
Life Science Investments in Pharma Services / CDMO / CRO / CSO – Private Equity
Goals & Objectives
Ampersand Capital Partners, a PE firm with $3 Billion in assets under management, has spent three decades investing in life science companies. The team requested a more modern, fresh, and reimagined Ampersand brand to showcase their 30 history of empowering founders and their companies to achieve their visions.
Strategic Approach
A new visual brand and messaging better reflected the Ampersand team’s specialized experience, unique understanding of the science behind portfolio operations, vast network of industry connections, and founder-friendly investment approach rooted in collaboration. We used portfolio founders and executives to share journeys from a portfolio company perspective, offering firsthand insight into Ampersand’s model.
Meeting & Exceeding KPIs
The project gave Ampersand a standout, modern brand focused on resonating with audiences across life sciences segments.
